Your browser doesn't support javascript.
loading
Effects of nivolumab in peritoneal carcinamatosis of malign melanoma in mouse model.
Duzgun, Ozgul; Sarici, Inanc Samil; Gokcay, Serkan; Ates, Kivilcim Eren; Yilmaz, Mehmet Bertan.
Affiliation
  • Duzgun O; MD, Department of Surgical Oncology, Umraniye Training and Research Hospital, Istanbul, Turkey. Conception, design, scientific, and intellectual content of the study; technical procedures.
  • Sarici IS; MD, Department of General Surgery, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey. Statistical analysis, manuscript writing, final approval.
  • Gokcay S; MD, Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey. Interpretation of data, critical revision.
  • Ates KE; MD, Department of Pathology, Faculty of Medicine, Cukurova University, Adana, Turkey. Histopathological examinations.
  • Yilmaz MB; Associate Professor, Department of Medical Biology, Faculty of Medicine, Cukurova University, Adana, Turkey. Critical revision.
Acta Cir Bras ; 32(12): 1006-1012, 2017 Dec.
Article in En | MEDLINE | ID: mdl-29319729

Full text: 1 Database: MEDLINE Main subject: Peritoneal Neoplasms / Peritoneum / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Acta Cir Bras Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Peritoneal Neoplasms / Peritoneum / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Acta Cir Bras Year: 2017 Type: Article